Kamada (KMDA) Dividend Coverage Ratio (2025 - 2026)
Kamada's (KMDA) quarterly Dividend Coverage Ratio came in at 0.77 in Q2 2026, down 115.27% on a YoY basis from 5.05 in Q2 2025, and down 267.16% quarter-over-quarter from 0.46 in Q1 2026.
Powered by 
Analysis
Kamada (KMDA) Dividend Coverage Ratio (2025 - 2026) Analysis & Trends
Kamada (KMDA) has reported Dividend Coverage Ratio for 2 consecutive years, with 0.77 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Dividend Coverage Ratio fell 115.27% year-over-year to 0.77; the trailing twelve-month figure through Mar 2026 stood at 8.36 (changed N/A YoY), and the FY2025 full-year result was 2.32, changed N/A from the prior year.
- Dividend Coverage Ratio retreated to 0.77 in Q2 2026 per KMDA's latest filing, from 0.46 in the prior quarter.
- Across five years, Dividend Coverage Ratio topped out at 0.8 in Q1 2025 and bottomed at 0.77 in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 1.74 |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | -10.18 |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 13.40 |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | - |
| 10 | Kamada | 473.57 Mn | 403.43 Mn | 22.47 Mn | 0.77 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -0.77 |
| Mar 31, 2026 | 0.46 |
| Jun 30, 2025 | -0.36 |
| Mar 31, 2025 | 0.80 |